State Street
BOLD

State Street’s Boundless Bio BOLD Stock Holding History

State Street’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6K Hold
15,962
– – ﹤0.01% 4221
2025
Q4 		$19.2K Hold
15,962
– – ﹤0.01% 4245
2025
Q3 		$19.6K Hold
15,962
– – ﹤0.01% 4247
2025
Q2 		$16.1K Sell
15,962
-32,224
-67% -$42.8K ﹤0.01% 4215
2025
Q1 		$72.8K Buy
48,186
+4,109
+9% +$8.52K ﹤0.01% 4031
2024
Q4 		$128K Buy
44,077
+18,712
+74% +$54.5K ﹤0.01% 3943
2024
Q3 		$88K Buy
25,365
+4,100
+19% +$14.9K ﹤0.01% 4001
2024
Q2 		$82.3K Buy
+21,265
New +$203K ﹤0.01% 4055

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

State Street's BOLD Position: Q1 2026 in Review

State Street held its Boundless Bio (BOLD) position steady in Q1 2026 at 15,962 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4221.

State Street first reported a position in BOLD in Q2 2024 and has held it in 8 quarters since. The position peaked at $128K in Q4 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • State Street held 15,962 shares of Boundless Bio worth $17.6K as of Q1 2026.
  • State Street left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4221 holding.
  • State Street first reported a position in Boundless Bio in Q2 2024 and has held it in 8 quarters since.
  • State Street's Boundless Bio position peaked at $128K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.